Connect with us


Revealed: Here’s how to treat Coronavirus



China has released the seventh version of the diagnosis and treatment guideline on the novel coronavirus disease (COVID-19).

Here are some drugs and therapies that have been recommended by the guideline, and some medicines that have been found to have the potential to defeat the virus and have entered clinical trials.


Chloroquine Phosphate, a widely used anti-malaria and autoimmune disease drug, has been used for more than 70 years.

The drug has been used in treating 285 critically ill COVID-19 patients in a hospital in Wuhan, and no obvious adverse reactions have been found so far.

In the latest version of the treatment guideline, Chloroquine Phosphate is recommended for COVID-19 patients from 18 to 65.

The amount for patients over 50 kg is 500 mg per dose twice a day for seven days.

The guideline also noted that patients should take less than three antiviral drugs.


Tocilizumab, with the common brand name Actemra, is an injectable synthetic protein that blocks the effects of IL-6 in patients with rheumatoid arthritis.

IL-6 is a protein that the body produces when there is inflammation.
The latest version of the guideline suggests the use of Tocilizumab in patients with an increasing level of IL-6 and with extensive lesions in both lungs or severe symptoms.

Chinese researchers have found that a cause of death for severe and critically ill patients infected with the novel coronavirus is cytokine storm, an overreaction of the immune system.

These patients are found with a higher level of IL-6 in their blood.

Last month, the increasing level of IL-6 was recommended as a warning sign that the patient’s situation could possibly deteriorate.

Currently, the drug is under clinical trials in 14 hospitals in Wuhan and a total of 272 severe patients had been treated with Tocilizumab as of March 5.


Convalescent plasma, processed from the plasma collected from recovered COVID-19 patients, contains a large number of protective antibodies.

As of February 28, 245 COVID-19 patients have received the therapy and 91 cases have shown improvement in clinical indicators and symptoms.

According to health authorities, plasma therapy has proved safe and effective.


Traditional Chinese medicine (TCM) has been proven effective in treating COVID-19 patients.

With TCM treatment, patients with mild symptoms have seen their fever or cough alleviated, according to medical experts.

For severely ill patients, TCM helped relieve symptoms and restore blood oxygen saturation, preventing the patients’ conditions from developing into critically ill cases.

TCM decoction Qingfei Paidu Soup has been recommended to medical institutions nationwide on February 6 after data analysis on 214 cases.

As of February 29, the decoction is used in 66 designated hospitals in 10 provincial-level regions in China.


Favipiravir, an influenza drug available on overseas markets, has been put in a parallel controlled study in Shenzhen, Guangdong Province, with 80 patients enlisted.

The initial outcome of the trial shows the drug has relatively obvious efficacy and low adverse reactions.

Experts have suggested expanding the trial to further observe and study its effect.

Remdesivir, developed against Ebola infections by American pharmaceutical company Gilead Sciences, has shown fairly good antiviral activity against the novel coronavirus at the cellular level.

Cao Bin, a respiratory expert who is leading the Remdesivir program, said on Wednesday that two trials for Remdesivir are going on smoothly and China will share the data with the international community after the program is completed.


Clinical studies on stem cell therapy, which can inhibit the overreaction of the body’s immune system, have also been carried out to treat severe patients.

As of February 21, four patients who have received the therapy have been discharged from hospital, and the trial is expected to be further expanded.
Currently, three kinds of stem cells— mesenchymal, lung and embryonic stem cells— are used in treatments.

Researchers usually inject stem cell products into the lungs.

Meanwhile, the Chinese Academy of Sciences has developed a new stem cell drug, CAStem, which has shown promising results in animal experiments.

The research team has applied for urgent assessment by the National Medical Products Administration.

Approvals by the ethics committee, and clinical observation and evaluation are in progress.

Several research and trials on applying stem cells to treat COVID-19 patients have been carried out in the country.
(Article courtesy of Xinhua)

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


He is a very dangerous man! Sonko’s daughter accuses senator of attempting to kill her



Lamu Senator Anwar Loitiptip and Saumu Mbuvi, daughter of former Nairobi Governor Mike Sonko, have announced their separation following wrangles and disagreement.

The reports were fuelled by photos and videos of Senator Loitiptip hanging out with a female friend.

Saumu, on Instagram, announced that the two have separated, claiming that she has undergone domestic violence under Loitiptip.

“These are the things he did to me,” wrote Saumu, in one of her photos showing a swollen face and bruised lips.

“He almost killed me. I will forever fight for women to stand for their rights. Never allow a man to be violent to you.”

She also claimed that the senator had neglected their child, leaving Saumu as the primary caregiver.

Loitiptip told that Saumu shared her father’s traits and was suffering from bipolar disorder, threatening to expose her past to prove his claim.

The two have been dating for months and at one point planned to get married. However, Sonko’s daughter clarified that the two had split before officiating their union.

“Wedding date confirmed,” she captioned a picture of herself and the senator in June 2020.

Her previous relationship with businessman cum politician Ben Gatu also ended after she accused him of being violent.

Continue Reading


US raises alarm over Covid-19 cases surge in Tanzania



The US government has revealed that there are significant cases of Covid-19 in Tanzania.

This is just a week after it advised its citizens against travelling to the East African country.

“The US Embassy is aware of a significant increase in the number of Covid-19 cases since January 2021,” the Embassy said.

In a Health alert, the US said the practice of Covid-19 mitigation and prevention measures remains limited.

The Tanzanian government has not released aggregate numbers on Covid-19 cases or deaths since April 2020.

“Healthcare facilities in Tanzania can become quickly overwhelmed in a healthcare crisis. Limited hospital capacity throughout Tanzania could result in life-threatening delays for emergency medical care,” US said.

The Department of State’s travel advisory level for Tanzania is Level 3.

The US Centre for Disease Control and Prevention says that travellers should avoid all travel to Tanzania.

The Embassy continues to recommend that all individuals take caution in day-to-day activities.

President John Magufuli assured the 58 million inhabitants that they need not worry about observing Covid-19 preventative measures.

Continue Reading


Siwachii wezi! Uhuru vows not to leave the country to thieves in 2022



President Uhuru Kenyatta on Wednesday made a surprising stop to lecture Nairobi residents after finishing his engagement at the National Cargo Deconsolidation Centre (NCDC-Nairobi).

The Head of State said he was angry at Nairobians for being against the Building Bridges Initiative (BBI) Bill stating that the report has given Nairobi more constituencies.

“If we have a BBI that says the people of Nairobi will have more constituencies and if it’s bursaries a child in Mathare who today receives Ksh500, how will that child study up to university level,” President Kenyatta said.

“But there is another child who gets Ksh100,000 in Busury per year is that right?… BBI is not for helping Raila or Uhuru it is for you,” he continued.

Uhuru went on to disclose that he has no plans to rule after his term is over and his interest is in finishing the job that Kenyans elected him to do.

Continue Reading